As demonstrated in the GEPIA database analysis, elevated KCTD10 expression correlates with prolonged disease-free survival (DFS) in patients, suggesting its potential role in inhibiting tumor metastasis (Figure 1J). Here, KCTD10 is linked to neoplasm.